The chief medical officer of QurAlis discussed the antisense oligonucleotide therapy QRL-201.
Angela Genge, MD, FRCPC, eMBA
Advertisement
Articles by Angela Genge, MD, FRCPC, eMBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Evaluating Gene Editing Therapy Reni-Cel for Severe Sickle Cell Disease
2
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
3
CGTLive®’s Weekly Rewind – December 12, 2025
4
MDA 2026 to Bring Keynote Insights and Evolving Neuromuscular Care
5
